Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/cea.14280 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Maximizing safety of ultrasound-guided intralymphatic allergen administration in the superficial inguinal lymph node.
Allergy
October 2024
Department of Otolaryngology, Division of Allergy and Immunology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
How to hit the allergy target: A critical appraisal of intralymphatic immunotherapy with practical recommendations on ultrasound-guided injections.
Allergy
August 2024
Department of Dermatology, University of Zurich, Zurich, Switzerland.
Background: Intralymphatic immunotherapy (ILIT) represents a promising novel approach treating allergic diseases. However, no standardized procedures or recommendations have been established or reported, despite the recognized fact that treatment efficacy relies on the ability to inject the allergen intranodally.
Objective: We aim to provide a critical appraisal of ILIT as a method of allergen immunotherapy and to deliver practical recommendations for accurate ILIT.
Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double-blind placebo-controlled clinical trial.
Clin Exp Allergy
August 2023
Allergy Center, University Hospital, Linköping, Sweden.
Introduction: There is a need to evaluate the safety and efficacy of intralymphatic immunotherapy (ILIT) for inducing tolerance in patients with allergic rhinitis.
Methods: Thirty-seven patients with seasonal allergic symptoms to birch and grass pollen and skin prick test >3 mm and/or IgE to birch and timothy >0.35 kU/L were randomized to either ILIT, with three doses of 0.
Ultrasound-guided intralymphatic immunotherapy: A single-center trial of a clinical skills training programme.
Clin Exp Allergy
February 2023
Institute for Clinical Medicine, Aarhus University, Aarhus, Denmark.
Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen.
Clin Exp Allergy
June 2022
Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Introduction: There is a need for a fast, efficient and safe way to induce tolerance in patients with severe allergic rhinitis. Intralymphatic immune therapy has been shown to be effective.
Methods: Patients with severe birch and timothy allergy were randomized and received three doses of 0.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!